Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk

BACKGROUND: Differences between gastrointestinal and cardiovascular effects of traditional NSAID or cyclooxygenase-2 selective inhibitor (coxib) are affected by drug, dose, duration, outcome definition, and patient gastrointestinal and cardiovascular risk factors. We calculated the absolute risk for...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, R Andrew, Derry, Sheena, McQuay, Henry J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001315/
https://www.ncbi.nlm.nih.gov/pubmed/17683540
http://dx.doi.org/10.1186/1471-2474-8-73

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001315/
https://www.ncbi.nlm.nih.gov/pubmed/17683540
http://dx.doi.org/10.1186/1471-2474-8-73

Ejemplares similares